Skip to main content
. 2024 Jun 25;15(8):1811–1820. doi: 10.1007/s13300-024-01611-9

Fig. 1.

Fig. 1

Patient flowchart. T2D type 2 diabetes, BG biguanide, DPP-4i dipeptidyl peptidase-4 inhibitor